Back
Servisfirst Bancshares Vs. Summit Therapeutics Industry Stock Comparison
Sell
50
SFBS
Servisfirst Bancshares
Last Price:
81.61
Seasonality Move:
10.13%
Buy
85
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
Sell
50
Servisfirst Bancshares (SFBS)
is a Sell
Is Servisfirst Bancshares a Buy, Sell or Hold?
- The current Servisfirst Bancshares [SFBS] share price is $80.24. The Score for SFBS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- SFBS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $29.48. The Score for SMMT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SFBS Stock Price Chart
What is Servisfirst Bancshares's stock price today?
-
The Servisfirst Bancshares share price today is $80.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFBS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $29.48
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
SFBS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.6 | Buy |
Relative Strength Index (14 RSI): | 59.21 | Buy |
Chaikin Money Flow: | 155966 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (75.25 - 80.17) | Buy |
Bollinger Bands (100): | (60.87 - 77.03) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.35 | Buy |
Relative Strength Index (14 RSI): | 80.76 | Buy |
Chaikin Money Flow: | -10383890 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.54 - 21.66) | Buy |
Bollinger Bands (100): | (4.24 - 14.54) | Buy |
SFBS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.16 | Buy |
20-day SMA: | 78.55 | Buy |
50-day SMA: | 76.1 | Buy |
200-day SMA: | 65.86 | Buy |
8-day EMA: | 77.91 | Buy |
20-day EMA: | 77.67 | Buy |
50-day EMA: | 75.04 | Buy |
200-day EMA: | 66.79 | Buy |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.3 | Buy |
20-day SMA: | 16.66 | Buy |
50-day SMA: | 12.66 | Buy |
200-day SMA: | 6.49 | Buy |
8-day EMA: | 23.98 | Buy |
20-day EMA: | 18.55 | Buy |
50-day EMA: | 13.95 | Buy |
200-day EMA: | 7.85 | Buy |
Servisfirst Bancshares Earnings Growth & SFBS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.20 per share, a decrease this year of $0.02 per share, and an increase next year of $0.66 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Servisfirst Bancshares Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |